QUARTERLY RESULTS Sakar Healthcare Q3 results: Revenue jumps 62.02% YoY to Rs 70.34 crore, net profit up 126.12% Feb 5, 2026
CORPORATES Sakar Healthcare gets EMA approval to manufacture Imatinib for Accord’s European market Dec 19, 2025
CORPORATES Sakar Healthcare receives nine new marketing authorisations for Oncology products in EU and emerging markets Nov 6, 2025